Mode
Text Size
Log in / Sign up

Blood biomarker variance in UK Biobank influenced by technical, demographic, and behavioral factorsWhy Blood Tests Fail to Predict Mental Health

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that technical, behavioral, and seasonal factors strongly influence blood biomarkers, attenuating associations with psychiatric disorders.

This cohort study in the UK Biobank assessed how technical, demographic, behavioral, and temporal covariates influence 29 blood-based biomarkers among approximately 500,000 participants. The primary aim was to quantify the proportion of biomarker variance explained by these factors. Secondary analyses explored associations between biomarkers and major depression, bipolar disorder, and schizophrenia.

Technical factors accounted for 1-6% of biomarker variance, while demographic factors explained 5-15%. Age-by-sex interactions were pronounced for lipids and sex hormones. Behavioral covariates, including BMI and smoking, strongly influenced inflammatory markers. Blood collection time was associated with chronotype, and diurnal rhythms were marked for testosterone, triglycerides, and immune markers. Inflammatory markers showed seasonal peaks in winter.

Adjusting for covariates attenuated or eliminated a substantial proportion of biomarker-disease associations. BMI was identified as the dominant confounder. Specific biomarker-disorder relationships require validation in clinical samples. Safety and tolerability data were not reported in this analysis.

Key limitations include the observational design and the need for validation in clinical samples. The study highlights that poor reproducibility of biomarkers may stem from insufficient biological signal or inconsistent handling of confounders. Standardized collection protocols, comprehensive covariate measurement, and transparent reporting are essential for reliable biomarker research.

Many doctors rely on blood work to check your physical health. But what if the same test could tell us about your mind?

New research shows that standard blood tests often give confusing results for mental health conditions. The problem isn't the biology. It is the messiness of real life.

The Hidden Mess in Your Blood

Imagine trying to hear a whisper in a noisy room. That is what scientists face when studying blood markers for depression or schizophrenia.

For years, researchers assumed that if a chemical in the blood changed, it meant a mental illness was present. But this study from the UK Biobank changed that view.

They looked at nearly 500,000 people. They found that many factors other than illness were moving the numbers around.

Mental health conditions like depression and bipolar disorder affect millions. We need better ways to diagnose them early.

Current methods rely on symptoms. This can be hard for patients to describe. Doctors want objective tests. Blood tests seem perfect.

But they are not ready yet. The numbers in a lab tube do not just reflect your brain. They reflect your age, your sex, your weight, and even the time of day you gave the sample.

The Surprising Twist

Scientists used to think they could ignore these background factors. They believed the disease signal was strong enough to stand alone.

But here is the twist. When they adjusted for these factors, many links between blood markers and mental illness disappeared.

Body mass index, or BMI, was the biggest culprit. Smoking also played a huge role. Even the time of day mattered.

Think of your blood chemistry like a busy highway. Cars represent different molecules. Some cars are there because of disease. Others are there because of lifestyle.

If you do not know which cars belong to which group, your traffic report will be wrong.

Your body has a clock. Hormones like testosterone rise and fall during the day. Some immune markers are higher in winter.

If you take a blood sample at 8 AM in January, it looks different from one taken at 4 PM in July.

If a researcher ignores this, they might think a person has an illness when they are simply having a normal day.

The team analyzed 29 common blood markers. They looked at how technical errors, age, behavior, and time affected the results.

Technical errors, like how the machine was calibrated, changed the numbers by 1 to 6 percent.

Demographic factors, like age and sex, changed them by 5 to 15 percent.

Behavioral factors were even stronger. Being overweight or smoking shifted the levels of inflammatory markers significantly.

When they tested these markers against major depression, bipolar disorder, and schizophrenia, the results were surprising.

Most of the connection vanished once they accounted for lifestyle factors. BMI was the dominant confounder.

This doesn't mean this treatment is available yet.

It means we must be more careful. We cannot assume a high marker means a disease. We must look at the whole picture.

This news is not bad. It is a call for better science.

If you have a blood test for mental health, ask how the lab handled these factors.

Doctors should measure your weight and smoking habits carefully. They should note the time of day for the test.

Until these standards are met, blood tests alone cannot diagnose mental illness.

Scientists now have a new framework. They know which factors to remove and which to study.

Future tests will need to be standardized. Everyone must collect samples the same way.

This will take time. We need to build trust in these new methods.

For now, talk to your doctor about your full history. Do not rely on a single number.

Your health is complex. So should our tests be.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Importance Blood-based biomarkers hold promise for psychiatric diagnosis and prognosis, yet clinical translation is constrained by poor reproducibility. Psychiatric biomarker studies are typically small, and demographic, behavioral, and temporal covariates often go undetected or cannot be adequately modeled. This may lead to residual confounding and unstable associations. Observations Leveraging UK Biobank data (N=~500,000), we systematically quantified how technical, demographic, behavioral, and temporal covariates influence 29 blood biomarkers commonly measured in research studies in psychiatry. Variance analyses showed substantial differences across biomarkers. Technical factors explained 1-6% and demographic factors explained 5-15% of the variance, with pronounced age-by-sex interactions for lipids and sex hormones. Behavioral covariates, particularly body mass index (BMI) and smoking, strongly influenced inflammatory markers. Temporal factors introduced systematic confounding. Chronotype was associated with blood collection time, multiple biomarkers exhibited marked diurnal rhythms (including testosterone, triglycerides, and immune markers), and inflammatory markers showed seasonal peaks in winter. In association analysis of biomarkers with major depression, bipolar disorder and schizophrenia, covariate adjustments attenuated or eliminated a substantial proportion of the biomarker-disorder associations, with BMI emerging as the dominant confounder. These findings demonstrate that such confounding structures exist and can be characterized in large cohorts, though specific biomarker-disorder relationships require validation in clinical samples. Conclusions and Relevance Poor reproducibility of biomarkers may not only stem from insufficient biological signal but also from inconsistent handling of confounders. We propose a systematic framework distinguishing technical factors (to be removed), demographic factors (addressed through adjustment or stratification), temporal factors (ideally controlled at design stages), and behavioral factors (requiring explicit causal reasoning). Associations robust to multiple adjustment strategies should be prioritized for clinical biomarker development. Standardized collection protocols, comprehensive covariate measurement, and transparent reporting across models are essential to improve reproducibility and identify biomarkers that reflect genuine illness-related pathophysiology.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.